Gary Guthart gave a glimpse of surgeons’ initial response to the new robot at the J.P. Morgan Healthcare Conference.

Intuitive has entered into this agreement, subject to regulatory approvals, with the current Intuitive technology distributors ab medica, Abex, Excelencia Robotica, and their affiliates to purchase ...

Intuitive Surgical's strong revenue growth and new product rollouts drive share price surge, but investors should be cautious ...

Intuitive Surgical’s da Vinci 5 robot launch, still in a limited phase, helped drive strong U.S. system placements in 2024, CEO Gary Guthart told investors Wednesday at the J.P. Morgan ...

Intuitive Surgical stock was rising Wednesday after the medical technology company’s preliminary fourth-quarter and full-year 2024 revenue topped Wall Street’s expectations. Shares of the ...

A meta-analysis of 230 studies found advantages to using Intuitive Surgical da Vinci robots in cancer procedures. The paper published in the medical journal Annals of Surgery looked at 30-day ...

Preliminary fourth quarter 2024 revenue of approximately $2.41 billion increased by 25% compared with $1.93 billion in the fourth quarter of 2023. Preliminary 2024 revenue of approximately $8.35 ...

Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic surgery. Our technologies include the da Vinci surgical ...